Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
McKesson
NYSE:MCK Community
1
Narratives
written by author
0
Comments
on narratives written by author
64
Fair Values set
on narratives written by author
Create a narrative
McKesson
Popular
Undervalued
Overvalued
McKesson
WA
Analyst Price Target
Consensus Narrative from 15 Analysts
Acquisition Of Florida Cancer Specialists And InspiroGene Launch Will Expand Future Oncology Services
Key Takeaways Growth in oncology and biopharma services, alongside strategic acquisitions, is poised to drive long-term revenue and earnings growth. Divestiture of non-core assets and cost optimization efforts enhance financial health, potentially improving margins and profitability.
View narrative
US$650.81
FV
8.2% undervalued
intrinsic discount
9.97%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
MCK
McKesson
Your Fair Value
US$
Current Price
US$597.71
25.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-4b
519b
2015
2018
2021
2024
2025
2027
2030
Revenue US$518.9b
Earnings US$4.3b
Advanced
Set as Fair Value